
A rarely noted aspect of the era of novel agents and explosive new knowledge in the clonal plasma cell diseases is how short the half-life of relevant information has become, and how this churning has challenged clinical thinking.

Your AI-Trained Oncology Knowledge Connection!


Published: June 15th 2011 | Updated: